This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gearhart, S. L. Articles by Wahl, R. Search for Related Content PubMed PubMed Citation Articles by Gearhart, S. L. Articles by Wahl, R.

Improved Staging With Pretreatment Positron Emission Tomography/Computed Tomography in Low Rectal Cancer

¹ Department of Surgery, Johns Hopkins Medical Institution, Blalock 656, 600 North Wolfe Street, Baltimore, Maryland 21287
² Department of Radiation Oncology, Johns Hopkins Medical Institution, Baltimore, Maryland 21287
³ Department of Radiology, Johns Hopkins Medical Institution, Baltimore, Maryland 21287

Correspondence: Address correspondence and reprint requests to: Susan L. Gearhart, MD; E-mail: sdemees1{at}jhmi.edu.

Background: ¹⁸F-Fluorodeoxyglucose (FDG)-positron emission tomography (PET) and computed tomography (CT) are widely accepted in the evaluation for metastatic or recurrent rectal cancer. Only spiral CT and transrectal ultrasonography (TRUS) are routinely used in the initial evaluation of primary rectal cancer. We wished to determine whether PET/CT could provide additional information in patients undergoing standard evaluation for primary rectal cancer.

Methods: Thirty-seven patients (mean age, 58 years; range, 26–90 years) with a previously untreated rectal cancer underwent TRUS or magnetic resonance imaging, spiral CT, and FDG-PET/CT. The tumor location (low, 6 cm; mid, 7–10 cm; or high, 10 cm) and carcinoembryonic antigen level were recorded. Discordant findings between spiral CT and FDG-PET/CT were confirmed by histological analysis or imaging follow-up.

Results: FDG-PET/CT identified discordant findings in 14 patients (38%), and this resulted in upstaging of 7 patients (50%) and downstaging of 3 patients (21%). Although node-positive disease on TRUS/magnetic resonance imaging was associated with discordant FDG-PET/CT findings, this was not statistically significant. Discordant PET/CT findings were significantly more common in patients with a low rectal cancer than in those with mid or high rectal cancer (13 vs. 1; P = .0027). The most common discordant finding was lymph node metastasis (n = 7; 50%). Histological confirmation of discordant FDG-PET/CT findings was performed in seven patients, and in no case did FDG-PET/CT prove to be inaccurate. Discordant PET/CT findings resulted in a deviation in the proposed treatment plan in 27% of patients (n = 10).

Conclusions: FDG-PET/CT frequently yields additional staging information in patients with low rectal cancer. Improved accuracy of pretreatment imaging with FDG-PET/CT will allow for more appropriate stage-specific therapy.

Key Words: Rectal cancer • Positron emission tomography • Computed tomography • Neoadjuvant therapy

This article has been cited by other articles:

				C. S. R. Nahas, T. Akhurst, H. Yeung, E. Riedel, A. J. Markowitz, B. D. Minsky, P. B. Paty, M. R. Weiser, L. K. Temple, W. D. Wong, et al. Positron Emission Tomography Detection of Distant Metastatic or Synchronous Disease in Patients with Locally Advanced Rectal Cancer Receiving Preoperative Chemoradiation Ann. Surg. Oncol., March 1, 2008; 15(3): 704 - 711. [Abstract] [Full Text] [PDF]

				S. H. Lee, K. C. Lee, J. H. Choi, J. H. Oh, J.-H. Baek, S. H. Park, and D. B. Shin Chemoradiotherapy Followed by Surgery in Rectal Cancer: Improved Local Control Using a Moderately High Pelvic Radiation Dose Jpn. J. Clin. Oncol., February 8, 2008; (2008) hym164v1. [Abstract] [Full Text] [PDF]

				V. R. Muthusamy and K. J. Chang Optimal Methods for Staging Rectal Cancer Clin. Cancer Res., November 15, 2007; 13(22): 6877s - 6884s. [Abstract] [Full Text] [PDF]

				R. A. Herbertson, S. T. Lee, N. Tebbutt, and A. M. Scott The expanding role of PET technology in the management of patients with colorectal cancer Ann. Onc., November 1, 2007; 18(11): 1774 - 1781. [Abstract] [Full Text] [PDF]

				K. Strobel, R. Dummer, D. B. Husarik, M. Perez Lago, T. F. Hany, and H. C. Steinert High-Risk Melanoma: Accuracy of FDG PET/CT with Added CT Morphologic Information for Detection of Metastases Radiology, August 1, 2007; 244(2): 566 - 574. [Abstract] [Full Text] [PDF]

				S. L. Gearhart Induction Chemoradiation for Rectal Cancer--Invited Critique Arch Surg, December 1, 2006; 141(12): 1253 - 1253. [Full Text] [PDF]